Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.

J Child Adolesc Psychopharmacol · 2018 · PMC5771543 · PMID 29189044

Europe PMC DOI

hedged sentence

0.3430

closest p · 6.9× alpha

0.3430

boldest claim

The sentences

did not reach statistical significancep = 0.343not close (p > 0.1)

Week 8 CGI-I response rate for desvenlafaxine (68.7%) was also greater than placebo, although this comparison did not reach statistical significance ( p = 0.343).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.